PDCD1 and cancer: Great heterogeneity exists among cells between brain metastases before and after PD-1 blockade treatment, as well as primary cancer and metastases at the single-cell transcriptome level, illustrating deeper understanding of brain metastasis of LSCC and insights for its effective immunotherapy.